GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we treat type 2 diabetes . These new drugs work by stimulating the body’s own GLP-1 substance , which supports https://peakbookmarks.com/story21779711/glp-1-a-significant-breakthrough-in-glucose-management